Avisi Technologies’ investigational device exemption (IDE) submission for its glaucoma treatment device VisiPlate has been approved by the US Food and Drug Administration (FDA).
The original Veterans Access, Choice, and Accountability Act of 2014 (also the Choice Act) primarily focused on healthcare ...
A particular concern for administrators is a new requirement that demands Medicaid recipients report their work status at least twice per year. A similar requirement implemented in Arkansas led to 18, ...
BVI's FineVision HP trifocal IOL, approved by the FDA, enhances the US premium IOL market with advanced optic design for multifocal vision correction. The lens features a diffractive optic design and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback